Stock Price Performance and Market Context
On 06 Jul 2026, KIMS’s share price touched Rs.858.15, setting a new 52-week high and surpassing previous records. The stock closed marginally below this peak at Rs.851.00, representing a day change of 0.03%, which was slightly below the Sensex’s 0.40% gain on the same day. Despite this, the stock’s trajectory over recent periods has been robust, outperforming the broader market consistently.
Over the past week, KIMS’s stock appreciated by 5.65%, compared to the Sensex’s 1.75%. The one-month gain stood at 7.76%, outpacing the Sensex’s 5.16%. More impressively, the three-month performance surged by 35.90%, dwarfing the Sensex’s 5.35% rise. Year-to-date, the stock has gained 40.17%, while the Sensex declined by 8.39%. Over a five-year horizon, KIMS’s stock has delivered a remarkable 299.17% return, significantly exceeding the Sensex’s 47.70% growth.
Technical Indicators and Trend Analysis
The technical outlook for KIMS remains bullish. The stock is trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling strong upward momentum. The overall technical trend shifted to bullish on 02 Jun 2026 at a price level of Rs.746.55, upgrading from a mildly bullish stance.
Weekly and monthly technical indicators largely support this positive trend. The MACD and Bollinger Bands show bullish signals on both weekly and monthly charts. The Relative Strength Index (RSI) indicates a bearish signal on the weekly timeframe but shows no signal monthly, suggesting some short-term caution amid the broader positive trend. Other indicators such as the KST and Dow Theory remain bullish or mildly bearish, reflecting a generally constructive technical environment.
Key support levels include the 52-week low of Rs.575.55, while immediate resistance was previously noted around Rs.798.61 (20-day moving average). The recent breakthrough beyond these levels to the all-time high underscores the stock’s strength.
Valuation Metrics and Market Capitalisation
KIMS is classified as a small-cap company with a market capitalisation grade reflecting this status. The valuation multiples as of 06 Jul 2026 show a price-to-earnings (P/E) ratio of 145x (TTM), indicating a premium valuation relative to earnings. The price-to-book value (P/BV) stands at 15.96x, while enterprise value multiples include EV/EBITDA at 49.92x and EV/EBIT at 77.17x. The EV/Sales multiple is 10.25x, and EV/Capital Employed is 6.25x. These elevated multiples reflect investor confidence in the company’s growth prospects and market position, despite the premium valuation.
Dividend metrics are not applicable, with no recent dividend payout or yield reported.
Quality Assessment and Financial Performance
The company maintains a good overall quality grade, supported by strong long-term financial performance. Management risk is rated as good, and the capital structure is sound, although growth is noted as below average in recent assessments. Key quality indicators include a five-year sales compound annual growth rate (CAGR) of 24.04% and a five-year EBIT growth of 11.48%. The average return on capital employed (ROCE) is a robust 20.10%, while return on equity (ROE) averages 17.81%, both signalling efficient capital utilisation.
Institutional holdings are high at 47.07%, reflecting significant participation by institutional investors. The company carries moderate leverage, with an average debt-to-EBITDA ratio of 2.15 and a net debt-to-equity ratio of 1.85, indicating a leveraged but manageable capital structure. The average EBIT to interest coverage ratio stands at 12.59x, suggesting adequate ability to service interest obligations.
Recent Financial Trends
Short-term financial trends show mixed signals. The latest quarterly net sales reached a high of Rs.1,074.60 crores, with PBDIT also at a peak of Rs.206.50 crores. However, operating profit to interest coverage has declined to 3.03 times, and profit before tax excluding other income fell by 41.3% compared to the previous four-quarter average. Similarly, quarterly profit after tax decreased by 32.8%, and the return on capital employed for the half-year dropped to 8.42%. The debt-equity ratio rose to 1.89 times, reflecting increased leverage, while inventory turnover ratio declined to 40.30 times. Interest expenses reached a quarterly high of Rs.68.10 crores, and earnings per share (EPS) for the quarter stood at Rs.1.06, the lowest in recent periods.
Despite these short-term pressures, the stock’s price performance and technical strength have remained resilient, culminating in the recent all-time high.
Delivery Volumes and Market Activity
Delivery volumes have shown a positive trend recently. The one-month delivery volume increased by 1.4%, with a notable 17.47% rise in delivery volume on the day of the all-time high compared to the five-day average. On 03 Jul 2026, delivery volume was 3.82 lakh shares, representing 63.28% of total volume, higher than the five-day average of 3.25 lakh shares (49.42%) and trailing one-month average of 4.05 lakh shares (50.12%). This indicates active trading interest and liquidity in the stock around the milestone event.
Summary of Market Rating
MarketsMOJO currently assigns a Mojo Score of 54.0 to Krishna Institute of Medical Sciences Ltd, with a Mojo Grade of Hold. This represents an upgrade from a previous Sell rating on 02 Jun 2026, reflecting improved market sentiment and technical positioning. The stock’s performance aligns closely with the hospital sector, maintaining an inline day performance relative to sector peers.
Conclusion
The attainment of an all-time high price of Rs.858.15 by Krishna Institute of Medical Sciences Ltd marks a significant achievement in its market journey. Supported by strong long-term growth, solid quality metrics, and a bullish technical trend, the stock has outperformed the broader market and its sector peers over multiple timeframes. While short-term financial indicators show some softness, the overall market response and valuation multiples underscore the company’s established position within the hospital sector. This milestone reflects the culmination of sustained efforts and market confidence in KIMS’s business fundamentals and strategic execution.
